WO2002055700A3 - Human genes and gene expression products isolated from human prostate - Google Patents

Human genes and gene expression products isolated from human prostate Download PDF

Info

Publication number
WO2002055700A3
WO2002055700A3 PCT/US2001/047349 US0147349W WO02055700A3 WO 2002055700 A3 WO2002055700 A3 WO 2002055700A3 US 0147349 W US0147349 W US 0147349W WO 02055700 A3 WO02055700 A3 WO 02055700A3
Authority
WO
WIPO (PCT)
Prior art keywords
genes
human
gene expression
polynucleotides
expression products
Prior art date
Application number
PCT/US2001/047349
Other languages
French (fr)
Other versions
WO2002055700A2 (en
WO2002055700A8 (en
Inventor
Jaime Escobedo
Pablo Dominguez Garcia
Altaf Kassam
George Lamson
Radoje Drmanac
Radomir Crkvenjakov
Mark Dickson
Snezana Drmanac
Ivan Labat
Dena Leshkowitz
David Kita
Veronica Garcia
William Lee Jones
Birgit Stache-Crain
Elizabeth M. Scott
Original Assignee
Chiron Corporation
Hyseq, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corporation, Hyseq, Inc. filed Critical Chiron Corporation
Priority to CA002430794A priority Critical patent/CA2430794A1/en
Priority to JP2002556746A priority patent/JP2004526429A/en
Priority to AU2002243300A priority patent/AU2002243300A1/en
Priority to EP01989188A priority patent/EP1379651A2/en
Publication of WO2002055700A2 publication Critical patent/WO2002055700A2/en
Publication of WO2002055700A3 publication Critical patent/WO2002055700A3/en
Publication of WO2002055700A8 publication Critical patent/WO2002055700A8/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

This invention relates to novel human polynucleotides and variants thereof, their encoded polypeptides and variants thereof, to genes corresponding to these polynucleotides and to proteins expressed by the genes. The invention also relates to diagnostics and therapeutics comprising such novel human polynucleotides, their corresponding genes or gene products, including probes, antisense nucleotides, and antibodies. The polynucleotides of the invention correspond to a polynucleotide comprising the sequence information of at least one of SEQ ID NOS:1-1477. The polypeptides of the invention correspond to a polypeptide comprising the amino acid sequence information of at least one of SEQ ID NOS:1478-1568.
PCT/US2001/047349 2000-12-07 2001-12-07 Human genes and gene expression products isolated from human prostate WO2002055700A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002430794A CA2430794A1 (en) 2000-12-07 2001-12-07 Human genes and gene expression products isolated from human prostate
JP2002556746A JP2004526429A (en) 2000-12-07 2001-12-07 Human genes and gene expression products isolated from human prostate
AU2002243300A AU2002243300A1 (en) 2000-12-07 2001-12-07 Human genes and gene expression products isolated from human prostate
EP01989188A EP1379651A2 (en) 2000-12-07 2001-12-07 Human genes and gene expression products isolated from human prostate

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US25464800P 2000-12-07 2000-12-07
US60/254,648 2000-12-07
US27568801P 2001-03-13 2001-03-13
US60/275,688 2001-03-13

Publications (3)

Publication Number Publication Date
WO2002055700A2 WO2002055700A2 (en) 2002-07-18
WO2002055700A3 true WO2002055700A3 (en) 2003-10-23
WO2002055700A8 WO2002055700A8 (en) 2005-01-06

Family

ID=26944174

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/047349 WO2002055700A2 (en) 2000-12-07 2001-12-07 Human genes and gene expression products isolated from human prostate

Country Status (5)

Country Link
EP (1) EP1379651A2 (en)
JP (1) JP2004526429A (en)
AU (1) AU2002243300A1 (en)
CA (1) CA2430794A1 (en)
WO (1) WO2002055700A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030215803A1 (en) * 2000-12-07 2003-11-20 Garcia Pablo Dominguez Human genes and gene expression products isolated from human prostate
AU2002246708A1 (en) 2000-12-15 2002-08-12 Agensys, Inc. Nucleic acid and encoded zinc transporter protein entitled 108p5h8 useful in treatment and detection of cancer
US7271240B2 (en) 2001-03-14 2007-09-18 Agensys, Inc. 125P5C8: a tissue specific protein highly expressed in various cancers
US8647826B2 (en) 2001-03-14 2014-02-11 Agensys, Inc. Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer
AU2003243151A1 (en) 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
JPWO2005080562A1 (en) * 2004-02-23 2007-08-02 弘 山元 Prostate cancer determination method

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999064631A1 (en) * 1998-06-12 1999-12-16 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
WO1999064594A2 (en) * 1998-06-11 1999-12-16 Chiron Corporation Genes and gene expression products that are differentially regulated in prostate cancer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999064594A2 (en) * 1998-06-11 1999-12-16 Chiron Corporation Genes and gene expression products that are differentially regulated in prostate cancer
WO1999064631A1 (en) * 1998-06-12 1999-12-16 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ADAM B-L ET AL: "IDENTIFICATION OF BLOMARKERS IN BENIGN PROSTATE HYPERPLASIA AND PROSTATE CARCINOMA BY DIFFERENTIAL DISPLAY", PROCEEDINGS OF THE ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH. TORONTO, MAR. 18 - 22, 1995, PHILADELPHIA, AACR, US, vol. MEETING 86, March 1995 (1995-03-01), pages 25, XP002923792, ISSN: 0197-016X *
CHEN M E ET AL: "ANDROGEN-INDEPENDENT HUMAN PROSTATE CANCER PROGRESSION: THE ISOLATION OF NOVEL STAGE-SPECIFIC SEQUENCES USING DIFFERENTIAL MRNADISPLAY", JOURNAL OF UROLOGY, BALTIMORE, MD, US, April 1995 (1995-04-01), pages 267A, XP002923791, ISSN: 0022-5347 *
DATABASE EMBL [online] 16 February 2000 (2000-02-16), XP002223603, retrieved from EBI Database accession no. AL139407 *
DATABASE EMBL [online] 25 January 1999 (1999-01-25), XP002223604, retrieved from EBI Database accession no. AQ348278 *
EMMANUEL DIAS NETO ET AL: "SHOTGUN SEQUENCING OF THE HUMAN TRANSCRIPTOME WITH ORF EXPRESSED SEQUENCE TAGS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 97, no. 7, 28 March 2000 (2000-03-28), pages 3491 - 3496, XP000996193, ISSN: 0027-8424 *
HELLER R A ET AL: "Discovery and analysis of inflammatory disease-related genes using cDNA microarrays", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, no. 94, pages 2150 - 2155, XP002076789, ISSN: 0027-8424 *

Also Published As

Publication number Publication date
WO2002055700A2 (en) 2002-07-18
EP1379651A2 (en) 2004-01-14
JP2004526429A (en) 2004-09-02
CA2430794A1 (en) 2002-07-18
WO2002055700A8 (en) 2005-01-06
AU2002243300A1 (en) 2002-07-24

Similar Documents

Publication Publication Date Title
WO2003050236A3 (en) Human genes and gene expression products isolated from human prostate
WO1999038972A8 (en) Human genes and gene expression products ii
WO1999033982A3 (en) Human genes and gene expression products i
WO1999058675A3 (en) Human genes and gene expression products v
WO2002014500A3 (en) Human genes and gene expression products
WO2001066753A3 (en) Human genes and gene expression products
CA2289914A1 (en) Igf-1 receptor interacting proteins (iips), genes coding therefor and uses thereof
WO2001070174A3 (en) Vegf-modulated genes and methods employing them
JP2002535956A5 (en)
DE69840333D1 (en) 2-M TRANSITION OF THE CELL CYCLE
WO2001066597A3 (en) Inflammation-related gene
WO2000004167A3 (en) Genes encoding sulfate assimilation proteins
WO2002055700A3 (en) Human genes and gene expression products isolated from human prostate
WO1999037764A3 (en) New members of the glypican gene family
WO2003031594A3 (en) Nucleotide and amino acid sequences relating to respiratory diseases and obesity
WO2004039943A3 (en) Human genes and gene expression products isolated from human prostate
WO2000059942A3 (en) Human obesity protein binding protrein-2 homolog and uses thereof
WO2000018916A3 (en) Human genes and gene expression products
WO1999054436A3 (en) Nucleic acids and proteins of c. elegans insulin-like genes and uses thereof
WO2001072781A3 (en) Human genes and expression products
WO2001078894A3 (en) Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease
MXPA01004353A (en) Chlamydia.
WO2002038607A3 (en) A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor
WO2001049714A3 (en) Nope polypeptides, encoding nucleic acids and methods of use
WO2003020912A3 (en) Novel clark protein and nucleic acid molecules and uses therefor

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2430794

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002556746

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2001989188

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001989188

Country of ref document: EP

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 29/2002 UNDER "PUBLISHED" ADD "SEQUENCE LISTING PART OF DESCRIPTION PUBLISHED SEPARATELY IN ELECTRONIC FORM AND AVAILABLE UPON REQUEST FROM THE INTERNATIONAL BUREAU"

WWW Wipo information: withdrawn in national office

Ref document number: 2001989188

Country of ref document: EP